embelin and resveratrol

embelin has been researched along with resveratrol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1
Chu, L; Ding, M; Huang, W; Li, H; Liu, XY; Xiao, J; Xu, H; Yang, D; Yang, Y	1
Khare, S; Khare, T; Palakurthi, S; Palakurthi, SS; Shah, BM	1

Reviews

1 review(s) available for embelin and resveratrol

Article	Year
Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease. International journal of molecular sciences, 2020, May-31, Volume: 21, Issue:11 Topics: Animals; Benzoquinones; Biological Products; Biomimetics; Caffeic Acids; Curcumin; Cytokines; Exosomes; Humans; Inflammation; Inflammatory Bowel Diseases; Insecta; Macromolecular Substances; Nanomedicine; Oxidative Stress; Phenylethyl Alcohol; Phytochemicals; Plant Extracts; Polysaccharides; Quercetin; Resveratrol; Stilbenes; Transcription Factors; Translational Research, Biomedical; Vasoactive Intestinal Peptide; Zingiber officinale	2020

Article

Year

Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.

International journal of molecular sciences, 2020, May-31, Volume: 21, Issue:11

Topics: Animals; Benzoquinones; Biological Products; Biomimetics; Caffeic Acids; Curcumin; Cytokines; Exosomes; Humans; Inflammation; Inflammatory Bowel Diseases; Insecta; Macromolecular Substances; Nanomedicine; Oxidative Stress; Phenylethyl Alcohol; Phytochemicals; Plant Extracts; Polysaccharides; Quercetin; Resveratrol; Stilbenes; Transcription Factors; Translational Research, Biomedical; Vasoactive Intestinal Peptide; Zingiber officinale

2020

Other Studies

2 other study(ies) available for embelin and resveratrol

Article	Year
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012
Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus. Journal of cellular and molecular medicine, 2015, Volume: 19, Issue:5 Topics: Adenoviridae; Animals; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Survival; Chromones; Enzyme Inhibitors; Female; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice, Inbred BALB C; Microscopy, Fluorescence; Morpholines; Neoplastic Stem Cells; Oncolytic Virotherapy; Oncolytic Viruses; Resveratrol; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Burden; Xenograft Model Antitumor Assays	2015

Article

Year

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012

Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.

Journal of cellular and molecular medicine, 2015, Volume: 19, Issue:5

Topics: Adenoviridae; Animals; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Survival; Chromones; Enzyme Inhibitors; Female; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice, Inbred BALB C; Microscopy, Fluorescence; Morpholines; Neoplastic Stem Cells; Oncolytic Virotherapy; Oncolytic Viruses; Resveratrol; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Burden; Xenograft Model Antitumor Assays

2015